Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$891.11
-2.8%
$918.89
$754.00
▼
$1,153.99
$263.51B1.292.10 million shs4.66 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$282.62
-1.1%
$267.12
$195.90
▼
$290.25
$682.52B0.227.47 million shs7.94 million shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.00%+5.79%+4.04%-12.82%+15.87%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%+3.49%+11.83%+8.90%+45.80%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$891.11
-2.8%
$918.89
$754.00
▼
$1,153.99
$263.51B1.292.10 million shs4.66 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$282.62
-1.1%
$267.12
$195.90
▼
$290.25
$682.52B0.227.47 million shs7.94 million shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.00%+5.79%+4.04%-12.82%+15.87%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%+3.49%+11.83%+8.90%+45.80%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.42
Hold$1,052.0418.06% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.73
Moderate Buy$275.92-2.37% Downside

Current Analyst Ratings Breakdown

Latest JNJ and GS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/2/2026
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Lower Price TargetNeutral$1,010.00 ➝ $1,000.00
10/28/2026
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
DowngradeHold (C+) ➝ Hold (C)
10/26/2026
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Set Price Target$942.00
10/23/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
DowngradeBuy (B+) ➝ Buy (B-)
10/23/2026
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
UpgradeHold ➝ Buy$1,200.00 ➝ $1,100.00
10/21/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
DowngradeBuy ➝ Hold
10/21/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
DowngradeBuy ➝ Hold
10/20/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Set Price Target$300.00
10/20/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Reiterated RatingBuy
10/19/2026
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Lower Price TargetMarket Perform$970.00 ➝ $950.00
10/16/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Boost Price TargetOverweight$275.00 ➝ $287.00
(Data available from 11/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$125.10B2.05$62.98 per share14.15$381.89 per share2.33
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$94.19B7.22$14.07 per share20.08$33.87 per share8.34
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$17.18B$69.5513.1412.060.8515.77%20.21%1.08%1/19/2027 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$26.80B$6.6026.6224.452.8016.20%31.64%13.04%1/26/2027 (Estimated)

Latest JNJ and GS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/13/2026Q3 2026
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$12.86$17.01+$4.15$17.01$16.83 billion$18.68 billion
10/13/2026Q3 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.53$2.59+$0.06$0.09$25.38 billion$25.40 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$20.002.24%+22.87%28.76%13 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.361.90%+5.25%81.21%64 Years

Latest JNJ and GS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/12/2026
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
quarterly$5.002.24%12/2/202612/2/202612/30/2026
10/13/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.342.15%11/24/202611/24/202612/8/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
3.20
0.61
0.61
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.44
1.02
0.74

Institutional Ownership

CompanyInstitutional Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
71.21%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%

Insider Ownership

CompanyInsider Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.55%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
47,400288.43 million286.85 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,2002.41 billion2.40 billionOptionable

Recent News About These Companies

J&J bets $2.2B on Ollin’s vision loss drug
Johnson & Johnson Stocks Edge Higher on $2.2 Billion Ollin Eye Deal
J&J outlays up to $3.3bn to buy ophthalmology specialist Ollin Biosciences
Sector Update: Healthcare Stocks Decline Late Afternoon
Johnson & Johnson (JNJ) Eyes Ollin Biosciences, Is It 19% Overvalued?
Johnson & Johnson Reportedly in Talks to Acquire Ollin Biosciences
Blackstone Life Sciences Announces $750 Million R&D Funding Agreement
Sector Update: Healthcare Stocks Advance Premarket Monday
J&J Stock Rallies More Than 10% in a Month: Time to Buy, Sell or Hold?

New MarketBeat Followers Over Time

Media Sentiment Over Time

The Goldman Sachs Group stock logo

The Goldman Sachs Group NYSE:GS

$891.11 -25.45 (-2.78%)
Closing price 03:59 PM Eastern
Extended Trading
$893.62 +2.51 (+0.28%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$282.62 -3.13 (-1.09%)
Closing price 03:59 PM Eastern
Extended Trading
$282.94 +0.32 (+0.11%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.